ORIENTBIO Inc. (002630) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.001x

Based on the latest financial reports, ORIENTBIO Inc. (002630) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩99.11 Million ≈ $67.16K USD) by net assets (₩69.62 Billion ≈ $47.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ORIENTBIO Inc. - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how ORIENTBIO Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ORIENTBIO Inc. balance sheet liabilities for a breakdown of total debt and financial obligations.

ORIENTBIO Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ORIENTBIO Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Royalty Management Holding Corporation NASDAQ:RMCO	0.002x
Sportshero Ltd AU:SHO	0.719x
Beshom Holdings Bhd KLSE:7668	0.009x
FRIWO AG F:CEA	-0.020x
Ekarat Engineering Public Company Limited BK:AKR	0.103x
XTPL SA WAR:XTP	-0.187x
Theranexus SA PA:ALTHX	-0.106x
AS Pro Kapital Grupp F:17E	-0.031x

Annual Cash Flow Conversion Efficiency for ORIENTBIO Inc. (2007–2025)

The table below shows the annual cash flow conversion efficiency of ORIENTBIO Inc. from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 002630 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	₩71.85 Billion ≈ $48.69 Million	₩752.29 Million ≈ $509.82K	0.010x	-76.28%
2024-03-31	₩85.10 Billion ≈ $57.67 Million	₩3.76 Billion ≈ $2.55 Million	0.044x	+171.70%
2023-03-31	₩71.39 Billion ≈ $48.38 Million	₩1.16 Billion ≈ $786.07K	0.016x	-42.52%
2022-03-31	₩83.19 Billion ≈ $56.38 Million	₩2.35 Billion ≈ $1.59 Million	0.028x	-84.30%
2021-03-31	₩48.55 Billion ≈ $32.90 Million	₩8.74 Billion ≈ $5.92 Million	0.180x	+339.61%
2020-03-31	₩51.96 Billion ≈ $35.21 Million	₩-3.90 Billion ≈ $-2.65 Million	-0.075x	+59.21%
2019-03-31	₩62.65 Billion ≈ $42.45 Million	₩-11.54 Billion ≈ $-7.82 Million	-0.184x	-648.68%
2018-03-31	₩79.92 Billion ≈ $54.16 Million	₩-1.97 Billion ≈ $-1.33 Million	-0.025x	+52.82%
2017-03-31	₩97.94 Billion ≈ $66.38 Million	₩-5.11 Billion ≈ $-3.46 Million	-0.052x	-621.81%
2016-03-31	₩91.29 Billion ≈ $61.87 Million	₩912.43 Million ≈ $618.34K	0.010x	-58.01%
2015-03-31	₩67.35 Billion ≈ $45.64 Million	₩1.60 Billion ≈ $1.09 Million	0.024x	-32.14%
2014-03-31	₩61.85 Billion ≈ $41.91 Million	₩2.17 Billion ≈ $1.47 Million	0.035x	-57.12%
2013-03-31	₩62.29 Billion ≈ $42.21 Million	₩5.09 Billion ≈ $3.45 Million	0.082x	+71.95%
2011-03-31	₩65.49 Billion ≈ $44.38 Million	₩3.11 Billion ≈ $2.11 Million	0.048x	-68.59%
2010-03-31	₩61.77 Billion ≈ $41.86 Million	₩9.35 Billion ≈ $6.34 Million	0.151x	+347.50%
2007-03-31	₩44.86 Billion ≈ $30.40 Million	₩1.52 Billion ≈ $1.03 Million	0.034x	--

About ORIENTBIO Inc.

KO:002630 Korea Biotechnology

Market Cap

$43.15 Million

₩63.67 Billion KRW

Market Cap Rank

#22428 Global

#1516 in Korea

Share Price

₩537.00

Change (1 day)

-1.29%

52-Week Range

₩524.00 - ₩1814.00

All Time High

₩6770.89